ANXA2 and urinary bladder carcinoma: It has also been reported that ANXA2 is highly expressed in bladder cancer tissues, and inhibiting ANXA2 can enhance the sensitivity of bladder cancer to doxorubicin, thereby improving the efficacy of chemotherapy37.